Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
Net Income Growth
5.64%
Quarterly · Period ending:
CANF Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported5.64%period ending
Latest reported5.64%period ending
CANF Quarterly Net Income YoY % (7.41% → 5.64%)
Year-over-year change
High-resolution chart · PNG
CANF net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 5.6399% | |
| 5.6399% | |
| -26.2299% | |
| -26.2299% | |
| -23.2247% | |
| -23.2247% | |
| -18.7349% | |
| -11.3224% | |
| -18.4731% | |
| 17.1482% | |
| 44.0948% | |
| 27.8165% | |
| 31.3605% | |
| 6.7916% | |
| 28.2419% | |
| 28.2059% | |
| 24.4175% | |
| -36.4217% | |
| -13.3498% | |
| -32.0388% | |
| 17.3131% | |
| 56.748% | |
| -108.0756% | |
| 12.6526% | |
| -27.1807% | |
| -137.0087% | |
| 49.0814% | |
| -1,565.5367% | |
| -146.0611% | |
| -6.4497% | |
| -219.1975% | |
| 64.7346% | |
| 41.0104% | |
| -34.073% | |
| 38.9129% | |
| 77.5731% | |
| -53.4271% | |
| 15.9095% | |
| -750.0925% | |
| 24.849% | |
| 21.2827% | |
| -344.4431% | |
| 116.2943% | |
| -216.2668% | |
| 1.8461% | |
| 80.0412% | |
| 49.5886% | |
| 31.2538% | |
| -14.215% | |
| 15.5267% | |
| 64.6412% | |
| -185.6788% | |
| -27.6417% | |
| -103.105% | |
| -179.272% | |
| 278.0092% | |
| 1.4837% | |
| 29.6933% | |
| -185.7269% | |
| 7.4118% |